C12N 2760/18322
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2760/18322 (New viral proteins or individual genes, new structural or functional aspects of) appears on 38 US grants and 71 published applications in this corpus.
Search patents in C12N- Granted patents
- 38
- Published applications
- 71
- Assignees
- 38
- Inventors
- 137
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 1 | 2 |
| 2004 | 0 | 3 |
| 2005 | 0 | 5 |
| 2006 | 0 | 3 |
| 2007 | 0 | 1 |
| 2008 | 1 | 1 |
| 2009 | 2 | 3 |
| 2010 | 1 | 4 |
| 2011 | 0 | 1 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 4 | 2 |
| 2015 | 1 | 2 |
| 2016 | 2 | 1 |
| 2017 | 5 | 2 |
| 2018 | 1 | 4 |
| 2019 | 4 | 2 |
| 2020 | 0 | 5 |
| 2021 | 3 | 1 |
| 2022 | 2 | 4 |
| 2023 | 2 | 4 |
| 2024 | 2 | 11 |
| 2025 | 5 | 7 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Recombinant human metapneumovirus F proteins and their use14 Jul 2026US 12,679,870 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Chimeric RSV and HMPV F proteins, immunogenic compositions, and methods of use10 Feb 2026US 12,544,436 B2Children's Healthcare of Atlanta, Inc.
- Prefusion-stabilized hMPV F proteins20 May 2025US 12,304,930 B2Board of Regents, The University of Texas System
- Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their use15 Apr 2025US 12,275,757 B2Institute for Research in Biomedicine
- Respiratory syncytial virus mRNA vaccine4 Mar 2025US 12,239,701 B2Vernagen, LLC
- Immunogenic compositions and uses thereof22 Jan 2026US 2026/0021175 A1Pfizer Inc.
- Recombinant metapneumovirus f proteins and their use25 Dec 2025US 2025/0387464 A1Institute for Research in Biomedicine
- Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their use21 Aug 2025US 2025/0263445 A1Institute for Research in Biomedicine
- Prefusion-stabilized hmpv f proteins14 Aug 2025US 2025/0257102 A1Board of Regents, The University of Texas System
- Methods and compositions for treating negative-sense single-stranded rna virus7 Aug 2025US 2025/0250548 A1Nationwide Children's Hospital, Inc.
Most cited
By later US patents
- Metapneumovirus strains and their use in vaccine formulations and sequences74US 8,722,341 B2MedImmune Vaccines, Inc. · 2014
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences35US 7,531,342 B2MedImmune, LLC · 2009
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences30US 7,449,324 B2MedImmune, LLC · 2008
- Virus causing respiratory tract illness in susceptible mammals29US 8,927,206 B2ViroNovative BV · 2015
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus27US 7,704,720 B2MedImmune, LLC · 2010